Nordic Nanovector, a biopharmaceutical company focused on haematological cancers, has appointed Malene Brondberg as interim CEO, replacing Peter Braun who leaves the position at the company for personal reasons. Brondberg…
Nordic Nanovector, a biopharmaceutical company focused on haematological cancers, has appointed Malene Brondberg as interim CEO, replacing Peter Braun who leaves the position at the company for personal reasons. Brondberg…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


